Journal article
The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial
Abstract
BackgroundTransfusion-transmitted infections (TTIs) are a global health challenge. One new approach to reduce TTIs is the use of pathogen reduction technology (PRT). In vitro, Mirasol PRT reduces the infectious load in whole blood (WB) by at least 99%. However, there are limited in vivo data on the safety and efficacy of Mirasol PRT. The objective of the Mirasol Evaluation of Reduction in Infections Trial (MERIT) is to investigate whether …
Authors
Kasirye R; Hume HA; Bloch EM; Lubega I; Kyeyune D; Shrestha R; Ddungu H; Musana HW; Dhabangi A; Ouma J
Journal
Trials, Vol. 23, No. 1,
Publisher
Springer Nature
Publication Date
December 2022
DOI
10.1186/s13063-022-06137-8
ISSN
1468-6708